12
Aug
When Pharmacovigilance Is an Afterthought: The Hidden Risks to Clinical Trials and Patients
In drug development, every decision affects both the science and the people behind it. But when pharmacovigilance (PV) is treated as an afterthought—rushed, under-resourced, or t